Search

Many virological tests have been implemented during the Coronavirus Disease 2019 (COVID-19) pandemic for diagnostic purposes, but they appear unsuitable for screening purposes. Furthermore, current screening strategies are not accurate enough to effectively curb the spread of the disease. Therefore, the present study was conducted within a controlled clinical environment to determine eventual detectable variations in the voice of COVID-19 patients, recovered and healthy subjects, and also to determine whether machine learning-based voice assessment (MLVA) can accurately discriminate between them, thus potentially serving as a more effective mass-screening tool. Three different subpopulations were consecutively recruited: positive COVID-19 patients, recovered COVID-19 patients and healthy individuals as controls. Positive patients were recruited within 10 days from nasal swab positivity. Recovery from COVID-19 was established clinically, virologically and radiologically. Healthy individuals reported no COVID-19 symptoms and yielded negative results at serological testing. All study participants provided three trials for multiple vocal tasks (sustained vowel phonation, speech, cough). All recordings were initially divided into three different binary classifications with a feature selection, ranking and cross-validated RBF-SVM pipeline. This brough a mean accuracy of 90.24%, a mean sensitivity of 91.15%, a mean specificity of 89.13% and a mean AUC of 0.94 across all tasks and all comparisons, and outlined the sustained vowel as the most effective vocal task for COVID discrimination. Moreover, a three-way classification was carried out on an external test set comprised of 30 subjects, 10 per class, with a mean accuracy of 80% and an accuracy of 100% for the detection of positive subjects. Within this assessment, recovered individuals proved to be the most difficult class to identify, and all the misclassified subjects were declared positive; this might be related to mid and short-term vocal traces of COVID-19, even after the clinical resolution of the infection. In conclusion, MLVA may accurately discriminate between positive COVID-19 patients, recovered COVID-19 patients and healthy individuals. Further studies should test MLVA among larger populations and asymptomatic positive COVID-19 patients to validate this novel screening technology and test its potential application as a potentially more effective surveillance strategy for COVID-19., (Copyright © 2021 The Voice Foundation. Published by Elsevier Inc. All rights reserved.)

Machine Learning (ML) algorithms within a human-computer framework are the leading force in speech emotion recognition (SER). However, few studies explore cross-corpora aspects of SER; this work aims to explore the feasibility and characteristics of a cross-linguistic, cross-gender SER. Three ML classifiers (SVM, Naïve Bayes and MLP) are applied to acoustic features, obtained through a procedure based on Kononenko's discretization and correlation-based feature selection. The system encompasses five emotions (disgust, fear, happiness, anger and sadness), using the Emofilm database, comprised of short clips of English movies and the respective Italian and Spanish dubbed versions, for a total of 1115 annotated utterances. The results see MLP as the most effective classifier, with accuracies higher than 90% for single-language approaches, while the cross-language classifier still yields accuracies higher than 80%. The results show cross-gender tasks to be more difficult than those involving two languages, suggesting greater differences between emotions expressed by male versus female subjects than between different languages. Four feature domains, namely, RASTA, F0, MFCC and spectral energy, are algorithmically assessed as the most effective, refining existing literature and approaches based on standard sets. To our knowledge, this is one of the first studies encompassing cross-gender and cross-linguistic assessments on SER.